K945608

Substantially Equivalent

ABUSIGN(TM) OPI, DOA-OPI, ACCUSIGN(TM) OPI, DOA-OPI, BIOSIGN(TM) OPI, DOA-OPI

Applicant: Princeton BioMeditech Corp.
Product code: DJG
Advisory panel: Clinical Toxicology
Date received: 1994-11-15
Decision date: 1995-02-10
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Princeton, NJ, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.